A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer
Clinical trial NCT04322539 · COMPLETED
Trial details
- NCT number
- NCT04322539
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-12
- Primary completion
- 2022-07-29
- Enrollment
- 691
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.